In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pharmion gets $65mm in mezzanine round

Executive Summary

Pharmion (in-licenses hematology and oncology drugs) raised $65mm in a mezzanine financing round led by Nomura International. Return investors Domain Associates, Versant Ventures, Aberdare Ventures, Abingworth Management, and members of Pharmion's management also participated along with new investors Bay City Capital, New Enterprise Associates, ProQuest Investments, NeoMed Management, Invemed Fund, HealthCap, Merlin BioMed, and Montagu Newhall.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies